Global Congestive Heart Failure (CHF) Treatment Devices Market Size, Share & Industry Trends Analysis Report By Product Type (Pacemakers, Implantable Cardioverter Defibrillators, Cardiac Resynchronization Therapy, and Ventricular Assist Devices), By Regional Outlook and Forecast, 2022 - 2028

The Global Congestive Heart Failure (CHF) Treatment Devices Market size is expected to reach $16.5 billion by 2028, rising at a market growth of 5.4% CAGR during the forecast period.

A cardiac device is employed to keep the heart in a regular rhythm. There are a variety of devices to choose from. An ICD (implantable cardiac defibrillator) is an electrical device that is implanted into the heart. An ICD constantly monitors the cardiac rhythm and, if it becomes abnormal, provides a mild shock to the heart muscle (arrhythmia). If a shock is required, it can be extremely unpleasant, but it will pass rapidly. Instead of a shock, some ICDs employ a pacing system. To restore normal heart rhythm, this type of ICD gives a rapid impulse to the heart muscle. A pacemaker can help the patient to avoid sudden cardiac arrest (SCA).

According to the Cleveland Clinic, electrical issues in the ventricles cause delays when they pump/contract in about 30% of people with heart failure. There is less oxygen-rich blood transported to the organs and muscles when the ventricles do not pump simultaneously. Pumping delays aggravate heart failure and raise the likelihood of death from the condition. A pacemaker is implanted in the patient's body as part of CRT treatment. The pacemaker is connected to three wires (leads) that send tiny electrical impulses to the heart muscle to maintain the ventricles pumping together. A CRT-D is a system that includes the capabilities of a CRT and an ICD. It prevents the ventricles from colliding. The CRT-D provides a shock to restore normal rhythm if they become out of sync due to ventricular tachycardia or fibrillation. CRT, with or without an ICD, improves the symptoms of about 75% of patients who do not find relief from their symptoms with medication. Cardiac resynchronization therapy improves the quality of life, survival, heart function, and exercise capacity, as well as lowers hospitalization risk.

COVID-19 Impact Analysis

The COVID-19 outbreak is one of the most hazardous pandemics that majorly demolished the worldwide economy. Various businesses were completely devastated while several were majorly impacted due to the advent of the pandemic. Governments all over the world were compelled to impose lockdowns across their countries, due to which, the manufacturing units of numerous goods were temporarily closed. Moreover, the global supply chain was also disrupted as a result of stringent travel restrictions imposed by governments. Owing to this, the growth of various industries was hampered.

Market Growth Factors

Increase in the prevalence of cardiac diseases all over the world

The failure of the ventricles in order to pump enough blood to the body's organs is the initial stage of congestive heart failure. Fluid builds up in the lungs, liver, belly, and lower body as a result of this. The technologies used to treat CHF include pacemakers, cardiac resynchronization therapy (CRT), implantable cardioverter defibrillators (ICDs), as well as ventricular assist devices. The market for congestive heart failure treatment devices is being driven by an increase in the number of cardiovascular ailments, technical advancements, and the number of cardiovascular procedures.

Rising number of initiatives by government and market players

One of the major factors that are propelling the growth of the congestive heart failure devices market is the increasing number of efforts and initiatives that are being taken by the government and market players all over the world. Governments in several countries have introduced a number of healthcare schemes, which, a patient can leverage for the treatment of several diseases and disorders. In addition, congestive heart failure is a very lethal and prevalent disorder, becoming the reason for the death of a considerable number of people all over the world each year. The inclusion of CHF in these policies is allowing people to take advantage of CHF treatment devices.

Marketing Restraining Factor:

High cost of these devices

One of the major factors that are impeding the deployment of congestive heart failure treatment devices is the high cost of these devices that are occurred in installing and operating these devices. There is a significant number of people that suffers from cardiac disorders and diseases all over the world. Congestive heart failure treatment devices are the most effective and quick treatment for these disorders. However, people all over the world are not able to leverage the full benefits of these devices due to their high cost. The implementation cost of these devices is significantly high due to the composition of various complex and advanced technologies.

Product Type Outlook

Based on Product Type, the market is segmented into Pacemakers, Implantable Cardioverter Defibrillators, Cardiac Resynchronization Therapy, and Ventricular Assist Devices. In 2021, the pacemakers segment acquired the largest revenue share of the congestive heart failure treatment devices market. The growth of this segment is rising due to an increase in pharmaceutical and medical device R&D, increased demand for congestive heart failure therapy devices for the treatment of heart failure, and an increase in pacemaker adoption. Moreover, it is a being more preferred by patients as well as surgeons due to its feature of maintaining the heart rhythm in a painless manner.

Congestive Heart Failure (CHF) Treatment Devices Market Report Coverage

Report Attribute	Details
Market size value in 2021	USD 11.5 Billion
Market size forecast in 2028	USD 16.5 Billion
Base Year	2021
Historical Period	2018 to 2020
Forecast Period	2022 to 2028
Revenue Growth Rate	CAGR of 5.4% from 2022 to 2028
Number of Pages	141
Number of Tables	184
Report coverage	Market Trends, Revenue Estimation and Forecast, Segmentation Analysis, Regional and Country Breakdown, Competitive Landscape, Companies Strategic Developments, Company Profiling
Segments covered	Product Type, Region
Country scope	US, Canada, Mexico, Germany, UK, France, Russia, Spain, Italy, China, Japan, India, South Korea, Singapore, Malaysia, Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria
Growth Drivers	Increase in the prevalence of cardiac diseases all over the world Rising number of initiatives by government and market players
Restraints	High cost of these devices

Regional Outlook

Based on Regions, the market is segmented into North America, Europe, Asia Pacific, and Latin America, Middle East & Africa. In 2021, North America procured the largest revenue share of the congestive heart failure treatment devices market. The constantly rising growth of the regional market is owing to the rise in the number of cardiac surgeries, the presence of key players, the development of the healthcare sector, and the presence of novel innovative ventricular assist and devices products in the region.

Free Valuable Insights: Global Congestive Heart Failure (CHF) Treatment Devices Market size to reach USD 16.5 Billion by 2028

KBV Cardinal Matrix - Congestive Heart Failure (CHF) Treatment Devices Market Competition Analysis

The major strategies followed by the market participants are Acquisitions. Based on the Analysis presented in the Cardinal matrix; Abbott Laboratories is the forerunners in the Congestive Heart Failure (CHF) Treatment Devices Market. Companies such as Medtronic PLC, AND Abiomed, Inc. are some of the key innovators in the Market.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Boston Scientific Corporation, MicroPort Scientific Corporation, Abbott Laboratories, Medtronic PLC, Abiomed, Inc., Berlin Heart GmbH, Jarvik Heart, Inc., Lepu Medical Technology (Beijing) Co., Ltd., BIOTRONIK SE & Co. KG, and Osypka Medical GmbH.

Recent Strategies Deployed in Congestive Heart Failure (CHF) Treatment Devices Market

» Partnerships, Collaborations and Agreements:

• Sep-2021: Medtronic teamed up with Mpirik, an A.I. healthcare technology company. Following this collaboration, the companies aimed to launch a pilot program to address disparities in treatment linked with sudden cardiac arrest prevention. Moreover, this program would provide a scalable and innovative approach to utilizing real-world clinical data along with more sophisticated methods than conventional manual chart reviews.
• Jun-2020: Berlin Heart signed an agreement with Scandinavian Real Heart, a developer of a total artificial heart. Following this agreement, the companies aimed to manufacture technology for polyurethane blood-contacting elements the RealHeart Total Artificial Heart.
• May-2020: Biotronik partnered with Acutus Medical, an arrhythmia management company. Following this partnership, the companies would offer a comprehensive mapping, ablation, electrophysiology, and accessory products portfolio for the catheter-based treatment of cardiac arrhythmias in the Asian and European markets.

» Acquisitions and Mergers:

• Feb-2022: Boston Scientific took over Baylis Medical Company, an advanced transseptal access solutions provider. This acquisition aimed to enable Boston Scientific to incorporate the Baylis platforms into its electrophysiology and structural heart portfolio in order to strengthen its foothold in the highest growth cardiology markets.
• Sep-2021: Boston Scientific acquired Devoro Medical, the developer of the WOLF Thrombectomy platform. Following this acquisition, the company aimed to integrate the innovative lytic-free and non-console WOLF technology into its portfolio. In addition, WOLF technology rapidly targets and captures blood clots leveraging finger-like prongs, which retrieve and remove thrombi in the venous and arterial systems.
• Sep-2021: Abbott took over Walk Vascular, a commercial-stage medical device company. With this acquisition, the company aimed to expand its peripheral vascular portfolio with the possession of Walk Vascular’s less-invasive mechanical aspiration thrombectomy system for the treatment of peripheral blood clots.
• Jun-2021: Abiomed completed its acquisition of preCARDIA, a vendor of a proprietary catheter and controller. This acquisition aimed to complement Abiomed’s product offerings in order to increase the options for acute decompensated heart failure patients.
• Jun-2021: Boston Scientific acquired Farapulse, a medical equipment manufacturer. This acquisition aimed to complement Boston Scientific's existing electrophysiology portfolio in order to include Farapulse's FARAPULSE Pulsed Field Ablation System.
• Jan-2021: Boston Scientific took over Preventice Solutions, mobile cardiac health solutions, and services provider. This acquisition aimed to strengthen Boston Scientific's foothold across the high-growth ambulatory electrocardiography space.

» Product Launches and Product Expansions:

• Jun-2021: MicroPort introduced BoreaTM and AlizeaTM pacemakers. The new CE Mark-certified devices are comprised of Bluetooth1 technology for simpler remote monitoring through the SmartView ConnectTM home monitor.
• Oct-2020: Abbott rolled out Implantable Cardioverter Defibrillator and Cardiac Resynchronisation Therapy Defibrillator. Through the launch of these next-generation heart rhythm management devices, the company aimed to optimize the treatment of abnormal heart rhythms and heart failure in Indian patients.
• Jun-2020: Boston Scientific launched DIRECTSENSE Technology, a solution for monitoring the effect of radiofrequency energy delivery, in the US. The new solution would offer data on the impedance around the catheter tip to scale the capacity of the tissue to react to RF energy before physicians deliver the therapy.

» Approvals and Trials:

• Feb-2022: Abbott received the US FDA approval for an expanded indication for its CardioMEMS HF System. Through this approval, the company aimed to enable the diagnosis of an increased number of heart failure patients. In addition, this expanded indication would grant the eligibility of leveraging advanced monitoring to an additional 1.2 million US patients.
• Jan-202: Boston Scientific received the CE Mark approval for its COGNIS cardiac resynchronization therapy defibrillator and TELIGEN implantable cardioverter-defibrillator. Through this approval, the company aimed to allow physicians to offer improved clinical options to their patients with two new platforms for the treatment of sudden cardiac death and heart failure.
• Dec-2021: MicroPort recieved CE Mark approval for its NAVIGO 4LV ARC and NAVIGO 4LV 2D under MDR – 2017/745 regulation. The new product range aimed to pace the left ventricle when linked with an implantable cardiac resynchronization device in heart failure patients.
• Jun-2021: Abiomed received the US FDA approval for its Impella RP, the company's latest heart pump with SmartAssist. This approval aimed to enable the treatment of patients with a body surface area more than or equivalent to 1.5m² with acute right heart failure or decompensation after the implantation of a left ventricular assist device, heart transplant, open-heart surgery, or myocardial infarction.
• Jul-2020: Abbott received the US FDA approval for its Gallant, a range of next-generation implantable cardioverter-defibrillator and cardiac resynchronization therapy defibrillator devices. Following this approval, the company aimed to offer new advantages for the treatment of heart rhythm disorders to patients. Moreover, the new products comprise a patient-preferred design along with optimized MRI compatibility and battery longevity.

Scope of the Study

Market Segments Covered in the Report:

By Product Type

• Pacemakers
• Implantable Cardioverter Defibrillators
• Cardiac Resynchronization Therapy
• Ventricular Assist Devices

By Geography

• North America
  • US
  • Canada
  • Mexico
  • Rest of North America
• Europe
  • Germany
  • UK
  • France
  • Russia
  • Spain
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Singapore
  • Malaysia
  • Rest of Asia Pacific
• LAMEA
  • Brazil
  • Argentina
  • UAE
  • Saudi Arabia
  • South Africa
  • Nigeria
  • Rest of LAMEA

Key Market Players

List of Companies Profiled in the Report:

• Boston Scientific Corporation
• MicroPort Scientific Corporation
• Abbott Laboratories
• Medtronic PLC
• Abiomed, Inc.
• Berlin Heart GmbH
• Jarvik Heart, Inc.
• Lepu Medical Technology (Beijing) Co., Ltd.
• BIOTRONIK SE & Co. KG
• Osypka Medical GmbH

Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Global Congestive Heart Failure (CHF) Treatment Devices Market, by Product Type
1.4.2 Global Congestive Heart Failure (CHF) Treatment Devices Market, by Geography
1.5 Methodology for the research

Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints

Chapter 3. Competition Analysis - Global
3.1 KBV Cardinal Matrix
3.2 Recent Industry Wide Strategic Developments
3.2.1 Partnerships, Collaborations and Agreements
3.2.2 Product Launches and Product Expansions
3.2.3 Acquisition and Mergers
3.2.4 Approvals and Trials
3.3 Top Winning Strategies
3.3.1 Key Leading Strategies: Percentage Distribution (2018-2022)
3.3.2 Key Strategic Move: (Acquisitions and Mergers: 2018, Jul – 2022, Feb) Leading Players

Chapter 4. Global Congestive Heart Failure (CHF) Treatment Devices Market by Product Type
4.1 Global Pacemakers Market by Region
4.2 Global Implantable Cardioverter Defibrillators Market by Region
4.3 Global Cardiac Resynchronization Therapy Market by Region
4.4 Global Ventricular Assist Devices Market by Region

Chapter 5. Global Congestive Heart Failure (CHF) Treatment Devices Market by Region
5.1 North America Congestive Heart Failure (CHF) Treatment Devices Market
5.1.1 North America Congestive Heart Failure (CHF) Treatment Devices Market by Product Type
5.1.1.1 North America Pacemakers Market by Country
5.1.1.2 North America Implantable Cardioverter Defibrillators Market by Country
5.1.1.3 North America Cardiac Resynchronization Therapy Market by Country
5.1.1.4 North America Ventricular Assist Devices Market by Country
5.1.2 North America Congestive Heart Failure (CHF) Treatment Devices Market by Country
5.1.2.1 US Congestive Heart Failure (CHF) Treatment Devices Market
5.1.2.1.1 US Congestive Heart Failure (CHF) Treatment Devices Market by Product Type
5.1.2.2 Canada Congestive Heart Failure (CHF) Treatment Devices Market
5.1.2.2.1 Canada Congestive Heart Failure (CHF) Treatment Devices Market by Product Type
5.1.2.3 Mexico Congestive Heart Failure (CHF) Treatment Devices Market
5.1.2.3.1 Mexico Congestive Heart Failure (CHF) Treatment Devices Market by Product Type
5.1.2.4 Rest of North America Congestive Heart Failure (CHF) Treatment Devices Market
5.1.2.4.1 Rest of North America Congestive Heart Failure (CHF) Treatment Devices Market by Product Type
5.2 Europe Congestive Heart Failure (CHF) Treatment Devices Market
5.2.1 Europe Congestive Heart Failure (CHF) Treatment Devices Market by Product Type
5.2.1.1 Europe Pacemakers Market by Country
5.2.1.2 Europe Implantable Cardioverter Defibrillators Market by Country
5.2.1.3 Europe Cardiac Resynchronization Therapy Market by Country
5.2.1.4 Europe Ventricular Assist Devices Market by Country
5.2.2 Europe Congestive Heart Failure (CHF) Treatment Devices Market by Country
5.2.2.1 Germany Congestive Heart Failure (CHF) Treatment Devices Market
5.2.2.1.1 Germany Congestive Heart Failure (CHF) Treatment Devices Market by Product Type
5.2.2.2 UK Congestive Heart Failure (CHF) Treatment Devices Market
5.2.2.2.1 UK Congestive Heart Failure (CHF) Treatment Devices Market by Product Type
5.2.2.3 France Congestive Heart Failure (CHF) Treatment Devices Market
5.2.2.3.1 France Congestive Heart Failure (CHF) Treatment Devices Market by Product Type
5.2.2.4 Russia Congestive Heart Failure (CHF) Treatment Devices Market
5.2.2.4.1 Russia Congestive Heart Failure (CHF) Treatment Devices Market by Product Type
5.2.2.5 Spain Congestive Heart Failure (CHF) Treatment Devices Market
5.2.2.5.1 Spain Congestive Heart Failure (CHF) Treatment Devices Market by Product Type
5.2.2.6 Italy Congestive Heart Failure (CHF) Treatment Devices Market
5.2.2.6.1 Italy Congestive Heart Failure (CHF) Treatment Devices Market by Product Type
5.2.2.7 Rest of Europe Congestive Heart Failure (CHF) Treatment Devices Market
5.2.2.7.1 Rest of Europe Congestive Heart Failure (CHF) Treatment Devices Market by Product Type
5.3 Asia Pacific Congestive Heart Failure (CHF) Treatment Devices Market
5.3.1 Asia Pacific Congestive Heart Failure (CHF) Treatment Devices Market by Product Type
5.3.1.1 Asia Pacific Pacemakers Market by Country
5.3.1.2 Asia Pacific Implantable Cardioverter Defibrillators Market by Country
5.3.1.3 Asia Pacific Cardiac Resynchronization Therapy Market by Country
5.3.1.4 Asia Pacific Ventricular Assist Devices Market by Country
5.3.2 Asia Pacific Congestive Heart Failure (CHF) Treatment Devices Market by Country
5.3.2.1 China Congestive Heart Failure (CHF) Treatment Devices Market
5.3.2.1.1 China Congestive Heart Failure (CHF) Treatment Devices Market by Product Type
5.3.2.2 Japan Congestive Heart Failure (CHF) Treatment Devices Market
5.3.2.2.1 Japan Congestive Heart Failure (CHF) Treatment Devices Market by Product Type
5.3.2.3 India Congestive Heart Failure (CHF) Treatment Devices Market
5.3.2.3.1 India Congestive Heart Failure (CHF) Treatment Devices Market by Product Type
5.3.2.4 South Korea Congestive Heart Failure (CHF) Treatment Devices Market
5.3.2.4.1 South Korea Congestive Heart Failure (CHF) Treatment Devices Market by Product Type
5.3.2.5 Singapore Congestive Heart Failure (CHF) Treatment Devices Market
5.3.2.5.1 Singapore Congestive Heart Failure (CHF) Treatment Devices Market by Product Type
5.3.2.6 Malaysia Congestive Heart Failure (CHF) Treatment Devices Market
5.3.2.6.1 Malaysia Congestive Heart Failure (CHF) Treatment Devices Market by Product Type
5.3.2.7 Rest of Asia Pacific Congestive Heart Failure (CHF) Treatment Devices Market
5.3.2.7.1 Rest of Asia Pacific Congestive Heart Failure (CHF) Treatment Devices Market by Product Type
5.4 LAMEA Congestive Heart Failure (CHF) Treatment Devices Market
5.4.1 LAMEA Congestive Heart Failure (CHF) Treatment Devices Market by Product Type
5.4.1.1 LAMEA Pacemakers Market by Country
5.4.1.2 LAMEA Implantable Cardioverter Defibrillators Market by Country
5.4.1.3 LAMEA Cardiac Resynchronization Therapy Market by Country
5.4.1.4 LAMEA Ventricular Assist Devices Market by Country
5.4.2 LAMEA Congestive Heart Failure (CHF) Treatment Devices Market by Country
5.4.2.1 Brazil Congestive Heart Failure (CHF) Treatment Devices Market
5.4.2.1.1 Brazil Congestive Heart Failure (CHF) Treatment Devices Market by Product Type
5.4.2.2 Argentina Congestive Heart Failure (CHF) Treatment Devices Market
5.4.2.2.1 Argentina Congestive Heart Failure (CHF) Treatment Devices Market by Product Type
5.4.2.3 UAE Congestive Heart Failure (CHF) Treatment Devices Market
5.4.2.3.1 UAE Congestive Heart Failure (CHF) Treatment Devices Market by Product Type
5.4.2.4 Saudi Arabia Congestive Heart Failure (CHF) Treatment Devices Market
5.4.2.4.1 Saudi Arabia Congestive Heart Failure (CHF) Treatment Devices Market by Product Type
5.4.2.5 South Africa Congestive Heart Failure (CHF) Treatment Devices Market
5.4.2.5.1 South Africa Congestive Heart Failure (CHF) Treatment Devices Market by Product Type
5.4.2.6 Nigeria Congestive Heart Failure (CHF) Treatment Devices Market
5.4.2.6.1 Nigeria Congestive Heart Failure (CHF) Treatment Devices Market by Product Type
5.4.2.7 Rest of LAMEA Congestive Heart Failure (CHF) Treatment Devices Market
5.4.2.7.1 Rest of LAMEA Congestive Heart Failure (CHF) Treatment Devices Market by Product Type

Chapter 6. Company Profiles
6.1 Boston Scientific Corporation
6.1.1 Company Overview
6.1.2 Financial Analysis
6.1.3 Segmental and Regional Analysis
6.1.4 Research & Development Expense
6.1.5 Recent strategies and developments:
6.1.5.1 Approvals and Trials:
6.1.5.2 Product Launches and Product Expansions:
6.1.5.3 Acquisition and Mergers:
6.2 MicroPort Scientific Corporation
6.2.1 Company Overview
6.2.2 Financial Analysis
6.2.3 Segmental and Regional Analysis
6.2.4 Research & Development Expense
6.2.5 Recent Strategies and Developments:
6.2.5.1 Approvals and Trials:
6.2.5.2 Product launches and Product Expansions:
6.3 Abbott Laboratories
6.3.1 Company Overview
6.3.2 Financial Analysis
6.3.3 Segmental and Regional Analysis
6.3.4 Research & Development Expense
6.3.5 Recent strategies and developments:
6.3.5.1 Partnerships, Collaborations, and Agreements:
6.3.5.2 Approvals and Trials:
6.3.5.3 Acquisitions and Mergers:
6.3.5.4 Product Launches and Product Expansions:
6.4 Medtronic PLC
6.4.1 Company overview
6.4.2 Financial Analysis
6.4.3 Segmental and Regional Analysis
6.4.4 Research & Development Expenses
6.4.5 Recent strategies and developments:
6.4.5.1 Partnerships, Collaborations, and Agreements:
6.5 Abiomed, Inc.
6.5.1 Company Overview
6.5.2 Financial Analysis
6.5.3 Regional Analysis
6.5.4 Research & Development Expenses
6.5.5 Recent strategies and developments:
6.5.5.1 Approvals and Trials:
6.5.5.2 Acquisition and Mergers:
6.6 Berlin Heart GmbH
6.6.1 Company Overview
6.6.2 Recent strategies and developments:
6.6.2.1 Partnerships, Collaborations, and Agreements:
6.7 Jarvik Heart, Inc.
6.7.1 Company Overview
6.8 Lepu Medical Technology (Beijing) Co., Ltd.
6.8.1 Company Overview
6.9 BIOTRONIK SE & Co. KG
6.9.1 Company Overview
6.9.2 Recent strategies and developments:
6.9.2.1 Partnerships, Collaborations and Agreements:
6.9.2.2 Approvals & Trials:
6.9.2.3 Product Launches and Product Expansions:
6.10. Osypka Medical GmbH
6.10.1 Company Overview

TABLE 1 Global Congestive Heart Failure (CHF) Treatment Devices Market, 2018 - 2021, USD Million
TABLE 2 Global Congestive Heart Failure (CHF) Treatment Devices Market, 2022 - 2028, USD Million
TABLE 3 Partnerships, Collaborations and Agreements– Congestive Heart Failure (CHF) Treatment Devices Market
TABLE 4 Product Launches And Product Expansions– Congestive Heart Failure (CHF) Treatment Devices Market
TABLE 5 Acquisition and Mergers– Congestive Heart Failure (CHF) Treatment Devices Market
TABLE 6 Approvals and Trials - Congestive Heart Failure (CHF) Treatment Devices Market
TABLE 7 Global Congestive Heart Failure (CHF) Treatment Devices Market by Product Type, 2018 - 2021, USD Million
TABLE 8 Global Congestive Heart Failure (CHF) Treatment Devices Market by Product Type, 2022 - 2028, USD Million
TABLE 9 Global Pacemakers Market by Region, 2018 - 2021, USD Million
TABLE 10 Global Pacemakers Market by Region, 2022 - 2028, USD Million
TABLE 11 Global Implantable Cardioverter Defibrillators Market by Region, 2018 - 2021, USD Million
TABLE 12 Global Implantable Cardioverter Defibrillators Market by Region, 2022 - 2028, USD Million
TABLE 13 Global Cardiac Resynchronization Therapy Market by Region, 2018 - 2021, USD Million
TABLE 14 Global Cardiac Resynchronization Therapy Market by Region, 2022 - 2028, USD Million
TABLE 15 Global Ventricular Assist Devices Market by Region, 2018 - 2021, USD Million
TABLE 16 Global Ventricular Assist Devices Market by Region, 2022 - 2028, USD Million
TABLE 17 Global Congestive Heart Failure (CHF) Treatment Devices Market by Region, 2018 - 2021, USD Million
TABLE 18 Global Congestive Heart Failure (CHF) Treatment Devices Market by Region, 2022 - 2028, USD Million
TABLE 19 North America Congestive Heart Failure (CHF) Treatment Devices Market, 2018 - 2021, USD Million
TABLE 20 North America Congestive Heart Failure (CHF) Treatment Devices Market, 2022 - 2028, USD Million
TABLE 21 North America Congestive Heart Failure (CHF) Treatment Devices Market by Product Type, 2018 - 2021, USD Million
TABLE 22 North America Congestive Heart Failure (CHF) Treatment Devices Market by Product Type, 2022 - 2028, USD Million
TABLE 23 North America Pacemakers Market by Country, 2018 - 2021, USD Million
TABLE 24 North America Pacemakers Market by Country, 2022 - 2028, USD Million
TABLE 25 North America Implantable Cardioverter Defibrillators Market by Country, 2018 - 2021, USD Million
TABLE 26 North America Implantable Cardioverter Defibrillators Market by Country, 2022 - 2028, USD Million
TABLE 27 North America Cardiac Resynchronization Therapy Market by Country, 2018 - 2021, USD Million
TABLE 28 North America Cardiac Resynchronization Therapy Market by Country, 2022 - 2028, USD Million
TABLE 29 North America Ventricular Assist Devices Market by Country, 2018 - 2021, USD Million
TABLE 30 North America Ventricular Assist Devices Market by Country, 2022 - 2028, USD Million
TABLE 31 North America Congestive Heart Failure (CHF) Treatment Devices Market by Country, 2018 - 2021, USD Million
TABLE 32 North America Congestive Heart Failure (CHF) Treatment Devices Market by Country, 2022 - 2028, USD Million
TABLE 33 US Congestive Heart Failure (CHF) Treatment Devices Market, 2018 - 2021, USD Million
TABLE 34 US Congestive Heart Failure (CHF) Treatment Devices Market, 2022 - 2028, USD Million
TABLE 35 US Congestive Heart Failure (CHF) Treatment Devices Market by Product Type, 2018 - 2021, USD Million
TABLE 36 US Congestive Heart Failure (CHF) Treatment Devices Market by Product Type, 2022 - 2028, USD Million
TABLE 37 Canada Congestive Heart Failure (CHF) Treatment Devices Market, 2018 - 2021, USD Million
TABLE 38 Canada Congestive Heart Failure (CHF) Treatment Devices Market, 2022 - 2028, USD Million
TABLE 39 Canada Congestive Heart Failure (CHF) Treatment Devices Market by Product Type, 2018 - 2021, USD Million
TABLE 40 Canada Congestive Heart Failure (CHF) Treatment Devices Market by Product Type, 2022 - 2028, USD Million
TABLE 41 Mexico Congestive Heart Failure (CHF) Treatment Devices Market, 2018 - 2021, USD Million
TABLE 42 Mexico Congestive Heart Failure (CHF) Treatment Devices Market, 2022 - 2028, USD Million
TABLE 43 Mexico Congestive Heart Failure (CHF) Treatment Devices Market by Product Type, 2018 - 2021, USD Million
TABLE 44 Mexico Congestive Heart Failure (CHF) Treatment Devices Market by Product Type, 2022 - 2028, USD Million
TABLE 45 Rest of North America Congestive Heart Failure (CHF) Treatment Devices Market, 2018 - 2021, USD Million
TABLE 46 Rest of North America Congestive Heart Failure (CHF) Treatment Devices Market, 2022 - 2028, USD Million
TABLE 47 Rest of North America Congestive Heart Failure (CHF) Treatment Devices Market by Product Type, 2018 - 2021, USD Million
TABLE 48 Rest of North America Congestive Heart Failure (CHF) Treatment Devices Market by Product Type, 2022 - 2028, USD Million
TABLE 49 Europe Congestive Heart Failure (CHF) Treatment Devices Market, 2018 - 2021, USD Million
TABLE 50 Europe Congestive Heart Failure (CHF) Treatment Devices Market, 2022 - 2028, USD Million
TABLE 51 Europe Congestive Heart Failure (CHF) Treatment Devices Market by Product Type, 2018 - 2021, USD Million
TABLE 52 Europe Congestive Heart Failure (CHF) Treatment Devices Market by Product Type, 2022 - 2028, USD Million
TABLE 53 Europe Pacemakers Market by Country, 2018 - 2021, USD Million
TABLE 54 Europe Pacemakers Market by Country, 2022 - 2028, USD Million
TABLE 55 Europe Implantable Cardioverter Defibrillators Market by Country, 2018 - 2021, USD Million
TABLE 56 Europe Implantable Cardioverter Defibrillators Market by Country, 2022 - 2028, USD Million
TABLE 57 Europe Cardiac Resynchronization Therapy Market by Country, 2018 - 2021, USD Million
TABLE 58 Europe Cardiac Resynchronization Therapy Market by Country, 2022 - 2028, USD Million
TABLE 59 Europe Ventricular Assist Devices Market by Country, 2018 - 2021, USD Million
TABLE 60 Europe Ventricular Assist Devices Market by Country, 2022 - 2028, USD Million
TABLE 61 Europe Congestive Heart Failure (CHF) Treatment Devices Market by Country, 2018 - 2021, USD Million
TABLE 62 Europe Congestive Heart Failure (CHF) Treatment Devices Market by Country, 2022 - 2028, USD Million
TABLE 63 Germany Congestive Heart Failure (CHF) Treatment Devices Market, 2018 - 2021, USD Million
TABLE 64 Germany Congestive Heart Failure (CHF) Treatment Devices Market, 2022 - 2028, USD Million
TABLE 65 Germany Congestive Heart Failure (CHF) Treatment Devices Market by Product Type, 2018 - 2021, USD Million
TABLE 66 Germany Congestive Heart Failure (CHF) Treatment Devices Market by Product Type, 2022 - 2028, USD Million
TABLE 67 UK Congestive Heart Failure (CHF) Treatment Devices Market, 2018 - 2021, USD Million
TABLE 68 UK Congestive Heart Failure (CHF) Treatment Devices Market, 2022 - 2028, USD Million
TABLE 69 UK Congestive Heart Failure (CHF) Treatment Devices Market by Product Type, 2018 - 2021, USD Million
TABLE 70 UK Congestive Heart Failure (CHF) Treatment Devices Market by Product Type, 2022 - 2028, USD Million
TABLE 71 France Congestive Heart Failure (CHF) Treatment Devices Market, 2018 - 2021, USD Million
TABLE 72 France Congestive Heart Failure (CHF) Treatment Devices Market, 2022 - 2028, USD Million
TABLE 73 France Congestive Heart Failure (CHF) Treatment Devices Market by Product Type, 2018 - 2021, USD Million
TABLE 74 France Congestive Heart Failure (CHF) Treatment Devices Market by Product Type, 2022 - 2028, USD Million
TABLE 75 Russia Congestive Heart Failure (CHF) Treatment Devices Market, 2018 - 2021, USD Million
TABLE 76 Russia Congestive Heart Failure (CHF) Treatment Devices Market, 2022 - 2028, USD Million
TABLE 77 Russia Congestive Heart Failure (CHF) Treatment Devices Market by Product Type, 2018 - 2021, USD Million
TABLE 78 Russia Congestive Heart Failure (CHF) Treatment Devices Market by Product Type, 2022 - 2028, USD Million
TABLE 79 Spain Congestive Heart Failure (CHF) Treatment Devices Market, 2018 - 2021, USD Million
TABLE 80 Spain Congestive Heart Failure (CHF) Treatment Devices Market, 2022 - 2028, USD Million
TABLE 81 Spain Congestive Heart Failure (CHF) Treatment Devices Market by Product Type, 2018 - 2021, USD Million
TABLE 82 Spain Congestive Heart Failure (CHF) Treatment Devices Market by Product Type, 2022 - 2028, USD Million
TABLE 83 Italy Congestive Heart Failure (CHF) Treatment Devices Market, 2018 - 2021, USD Million
TABLE 84 Italy Congestive Heart Failure (CHF) Treatment Devices Market, 2022 - 2028, USD Million
TABLE 85 Italy Congestive Heart Failure (CHF) Treatment Devices Market by Product Type, 2018 - 2021, USD Million
TABLE 86 Italy Congestive Heart Failure (CHF) Treatment Devices Market by Product Type, 2022 - 2028, USD Million
TABLE 87 Rest of Europe Congestive Heart Failure (CHF) Treatment Devices Market, 2018 - 2021, USD Million
TABLE 88 Rest of Europe Congestive Heart Failure (CHF) Treatment Devices Market, 2022 - 2028, USD Million
TABLE 89 Rest of Europe Congestive Heart Failure (CHF) Treatment Devices Market by Product Type, 2018 - 2021, USD Million
TABLE 90 Rest of Europe Congestive Heart Failure (CHF) Treatment Devices Market by Product Type, 2022 - 2028, USD Million
TABLE 91 Asia Pacific Congestive Heart Failure (CHF) Treatment Devices Market, 2018 - 2021, USD Million
TABLE 92 Asia Pacific Congestive Heart Failure (CHF) Treatment Devices Market, 2022 - 2028, USD Million
TABLE 93 Asia Pacific Congestive Heart Failure (CHF) Treatment Devices Market by Product Type, 2018 - 2021, USD Million
TABLE 94 Asia Pacific Congestive Heart Failure (CHF) Treatment Devices Market by Product Type, 2022 - 2028, USD Million
TABLE 95 Asia Pacific Pacemakers Market by Country, 2018 - 2021, USD Million
TABLE 96 Asia Pacific Pacemakers Market by Country, 2022 - 2028, USD Million
TABLE 97 Asia Pacific Implantable Cardioverter Defibrillators Market by Country, 2018 - 2021, USD Million
TABLE 98 Asia Pacific Implantable Cardioverter Defibrillators Market by Country, 2022 - 2028, USD Million
TABLE 99 Asia Pacific Cardiac Resynchronization Therapy Market by Country, 2018 - 2021, USD Million
TABLE 100 Asia Pacific Cardiac Resynchronization Therapy Market by Country, 2022 - 2028, USD Million
TABLE 101 Asia Pacific Ventricular Assist Devices Market by Country, 2018 - 2021, USD Million
TABLE 102 Asia Pacific Ventricular Assist Devices Market by Country, 2022 - 2028, USD Million
TABLE 103 Asia Pacific Congestive Heart Failure (CHF) Treatment Devices Market by Country, 2018 - 2021, USD Million
TABLE 104 Asia Pacific Congestive Heart Failure (CHF) Treatment Devices Market by Country, 2022 - 2028, USD Million
TABLE 105 China Congestive Heart Failure (CHF) Treatment Devices Market, 2018 - 2021, USD Million
TABLE 106 China Congestive Heart Failure (CHF) Treatment Devices Market, 2022 - 2028, USD Million
TABLE 107 China Congestive Heart Failure (CHF) Treatment Devices Market by Product Type, 2018 - 2021, USD Million
TABLE 108 China Congestive Heart Failure (CHF) Treatment Devices Market by Product Type, 2022 - 2028, USD Million
TABLE 109 Japan Congestive Heart Failure (CHF) Treatment Devices Market, 2018 - 2021, USD Million
TABLE 110 Japan Congestive Heart Failure (CHF) Treatment Devices Market, 2022 - 2028, USD Million
TABLE 111 Japan Congestive Heart Failure (CHF) Treatment Devices Market by Product Type, 2018 - 2021, USD Million
TABLE 112 Japan Congestive Heart Failure (CHF) Treatment Devices Market by Product Type, 2022 - 2028, USD Million
TABLE 113 India Congestive Heart Failure (CHF) Treatment Devices Market, 2018 - 2021, USD Million
TABLE 114 India Congestive Heart Failure (CHF) Treatment Devices Market, 2022 - 2028, USD Million
TABLE 115 India Congestive Heart Failure (CHF) Treatment Devices Market by Product Type, 2018 - 2021, USD Million
TABLE 116 India Congestive Heart Failure (CHF) Treatment Devices Market by Product Type, 2022 - 2028, USD Million
TABLE 117 South Korea Congestive Heart Failure (CHF) Treatment Devices Market, 2018 - 2021, USD Million
TABLE 118 South Korea Congestive Heart Failure (CHF) Treatment Devices Market, 2022 - 2028, USD Million
TABLE 119 South Korea Congestive Heart Failure (CHF) Treatment Devices Market by Product Type, 2018 - 2021, USD Million
TABLE 120 South Korea Congestive Heart Failure (CHF) Treatment Devices Market by Product Type, 2022 - 2028, USD Million
TABLE 121 Singapore Congestive Heart Failure (CHF) Treatment Devices Market, 2018 - 2021, USD Million
TABLE 122 Singapore Congestive Heart Failure (CHF) Treatment Devices Market, 2022 - 2028, USD Million
TABLE 123 Singapore Congestive Heart Failure (CHF) Treatment Devices Market by Product Type, 2018 - 2021, USD Million
TABLE 124 Singapore Congestive Heart Failure (CHF) Treatment Devices Market by Product Type, 2022 - 2028, USD Million
TABLE 125 Malaysia Congestive Heart Failure (CHF) Treatment Devices Market, 2018 - 2021, USD Million
TABLE 126 Malaysia Congestive Heart Failure (CHF) Treatment Devices Market, 2022 - 2028, USD Million
TABLE 127 Malaysia Congestive Heart Failure (CHF) Treatment Devices Market by Product Type, 2018 - 2021, USD Million
TABLE 128 Malaysia Congestive Heart Failure (CHF) Treatment Devices Market by Product Type, 2022 - 2028, USD Million
TABLE 129 Rest of Asia Pacific Congestive Heart Failure (CHF) Treatment Devices Market, 2018 - 2021, USD Million
TABLE 130 Rest of Asia Pacific Congestive Heart Failure (CHF) Treatment Devices Market, 2022 - 2028, USD Million
TABLE 131 Rest of Asia Pacific Congestive Heart Failure (CHF) Treatment Devices Market by Product Type, 2018 - 2021, USD Million
TABLE 132 Rest of Asia Pacific Congestive Heart Failure (CHF) Treatment Devices Market by Product Type, 2022 - 2028, USD Million
TABLE 133 LAMEA Congestive Heart Failure (CHF) Treatment Devices Market, 2018 - 2021, USD Million
TABLE 134 LAMEA Congestive Heart Failure (CHF) Treatment Devices Market, 2022 - 2028, USD Million
TABLE 135 LAMEA Congestive Heart Failure (CHF) Treatment Devices Market by Product Type, 2018 - 2021, USD Million
TABLE 136 LAMEA Congestive Heart Failure (CHF) Treatment Devices Market by Product Type, 2022 - 2028, USD Million
TABLE 137 LAMEA Pacemakers Market by Country, 2018 - 2021, USD Million
TABLE 138 LAMEA Pacemakers Market by Country, 2022 - 2028, USD Million
TABLE 139 LAMEA Implantable Cardioverter Defibrillators Market by Country, 2018 - 2021, USD Million
TABLE 140 LAMEA Implantable Cardioverter Defibrillators Market by Country, 2022 - 2028, USD Million
TABLE 141 LAMEA Cardiac Resynchronization Therapy Market by Country, 2018 - 2021, USD Million
TABLE 142 LAMEA Cardiac Resynchronization Therapy Market by Country, 2022 - 2028, USD Million
TABLE 143 LAMEA Ventricular Assist Devices Market by Country, 2018 - 2021, USD Million
TABLE 144 LAMEA Ventricular Assist Devices Market by Country, 2022 - 2028, USD Million
TABLE 145 LAMEA Congestive Heart Failure (CHF) Treatment Devices Market by Country, 2018 - 2021, USD Million
TABLE 146 LAMEA Congestive Heart Failure (CHF) Treatment Devices Market by Country, 2022 - 2028, USD Million
TABLE 147 Brazil Congestive Heart Failure (CHF) Treatment Devices Market, 2018 - 2021, USD Million
TABLE 148 Brazil Congestive Heart Failure (CHF) Treatment Devices Market, 2022 - 2028, USD Million
TABLE 149 Brazil Congestive Heart Failure (CHF) Treatment Devices Market by Product Type, 2018 - 2021, USD Million
TABLE 150 Brazil Congestive Heart Failure (CHF) Treatment Devices Market by Product Type, 2022 - 2028, USD Million
TABLE 151 Argentina Congestive Heart Failure (CHF) Treatment Devices Market, 2018 - 2021, USD Million
TABLE 152 Argentina Congestive Heart Failure (CHF) Treatment Devices Market, 2022 - 2028, USD Million
TABLE 153 Argentina Congestive Heart Failure (CHF) Treatment Devices Market by Product Type, 2018 - 2021, USD Million
TABLE 154 Argentina Congestive Heart Failure (CHF) Treatment Devices Market by Product Type, 2022 - 2028, USD Million
TABLE 155 UAE Congestive Heart Failure (CHF) Treatment Devices Market, 2018 - 2021, USD Million
TABLE 156 UAE Congestive Heart Failure (CHF) Treatment Devices Market, 2022 - 2028, USD Million
TABLE 157 UAE Congestive Heart Failure (CHF) Treatment Devices Market by Product Type, 2018 - 2021, USD Million
TABLE 158 UAE Congestive Heart Failure (CHF) Treatment Devices Market by Product Type, 2022 - 2028, USD Million
TABLE 159 Saudi Arabia Congestive Heart Failure (CHF) Treatment Devices Market, 2018 - 2021, USD Million
TABLE 160 Saudi Arabia Congestive Heart Failure (CHF) Treatment Devices Market, 2022 - 2028, USD Million
TABLE 161 Saudi Arabia Congestive Heart Failure (CHF) Treatment Devices Market by Product Type, 2018 - 2021, USD Million
TABLE 162 Saudi Arabia Congestive Heart Failure (CHF) Treatment Devices Market by Product Type, 2022 - 2028, USD Million
TABLE 163 South Africa Congestive Heart Failure (CHF) Treatment Devices Market, 2018 - 2021, USD Million
TABLE 164 South Africa Congestive Heart Failure (CHF) Treatment Devices Market, 2022 - 2028, USD Million
TABLE 165 South Africa Congestive Heart Failure (CHF) Treatment Devices Market by Product Type, 2018 - 2021, USD Million
TABLE 166 South Africa Congestive Heart Failure (CHF) Treatment Devices Market by Product Type, 2022 - 2028, USD Million
TABLE 167 Nigeria Congestive Heart Failure (CHF) Treatment Devices Market, 2018 - 2021, USD Million
TABLE 168 Nigeria Congestive Heart Failure (CHF) Treatment Devices Market, 2022 - 2028, USD Million
TABLE 169 Nigeria Congestive Heart Failure (CHF) Treatment Devices Market by Product Type, 2018 - 2021, USD Million
TABLE 170 Nigeria Congestive Heart Failure (CHF) Treatment Devices Market by Product Type, 2022 - 2028, USD Million
TABLE 171 Rest of LAMEA Congestive Heart Failure (CHF) Treatment Devices Market, 2018 - 2021, USD Million
TABLE 172 Rest of LAMEA Congestive Heart Failure (CHF) Treatment Devices Market, 2022 - 2028, USD Million
TABLE 173 Rest of LAMEA Congestive Heart Failure (CHF) Treatment Devices Market by Product Type, 2018 - 2021, USD Million
TABLE 174 Rest of LAMEA Congestive Heart Failure (CHF) Treatment Devices Market by Product Type, 2022 - 2028, USD Million
TABLE 175 key Information – Boston Scientific Corporation
TABLE 176 key Information – MicroPort Scientific Corporation
TABLE 177 Key Information – Abbott Laboratories
TABLE 178 Key Information – Medtronic PLC
TABLE 179 Key Information – ABIOMED, Inc.
TABLE 180 Key Information – Berlin Heart GmbH
TABLE 181 Key Information – JARVIK HEART, INC.
TABLE 182 Key Information – Lepu Medical Technology (Beijing) Co., Ltd.
TABLE 183 Key Information – BIOTRONIK SE & Co. KG
TABLE 184 Key Information – Osypka Medical GmbH

List of Figures
FIG 1 Methodology for the research
FIG 2 KBV Cardinal Matrix
FIG 3 Key Leading Strategies: Percentage Distribution (2018-2022)
FIG 4 Key Strategic Move: (Acquisitions and Mergers: 2018, Jul – 2022, Feb) Leading Players
FIG 5 Global Congestive Heart Failure (CHF) Treatment Devices Market by Share Product Type, 2021
FIG 6 Global Congestive Heart Failure (CHF) Treatment Devices Market Share by Product Type, 2028
FIG 7 Global Congestive Heart Failure (CHF) Treatment Devices Market by Product Type, 2018 - 2028, USD Million
FIG 8 Global Congestive Heart Failure (CHF) Treatment Devices Market Share by Region, 2021
FIG 9 Global Congestive Heart Failure (CHF) Treatment Devices Market Share by Region, 2028
FIG 10 Global Congestive Heart Failure (CHF) Treatment Devices Market by Region, 2018 - 2028, USD Million
FIG 11 Recent strategies and developments: Boston Scientific Corporation
FIG 12 Recent Strategies and Developments: MicroPort Scientific Corporation
FIG 13 Recent strategies and developments: Abbott Laboratories
FIG 14 Recent strategies and developments: Abiomed, Inc.